Full Text
The Full Text of this article is available as a PDF (17.2 KB).
References
- 1. Anand IS, Florea VC, Fisher L: Surrogate end points in heart failure. J Am Coll Cardiol 2002; 39:1414–1421 [DOI] [PubMed] [Google Scholar]
- 2. Cintron G, Johnson G, Francis G, Cobb F, Cohn JN: Prognostic significance of serial changes in left ventricular ejection fraction in patients with congestive heart failure. The V‐HeFT VA Cooperative Studies Group. Circulation 1993; 87(6 suppl): VI17–123 [PubMed] [Google Scholar]
- 3. Poole‐Wilson PA: Treatment of acute heart failure: Out with the old, in with the new. J Am Med Assoc 2002; 287:1578–1580 [DOI] [PubMed] [Google Scholar]
- 4. Stevenson LW, Bellil D, Grover‐McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR: Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60:654–658 [DOI] [PubMed] [Google Scholar]
- 5. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW: Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002; 39:1623–1629 [DOI] [PubMed] [Google Scholar]
- 6. Hobbs RE, Miller LW, Bott‐Silverman C, James KB, Rincon G, Grossbard EB: Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1996; 78:896–901 [DOI] [PubMed] [Google Scholar]
- 7. Mills RM, LeJemtel TH, Horton DP, Liang C, Lang R, Silver MA: Sustained hemodynamic effects of an infusion of nesiritide (human B‐type natriuretic peptide) in heart failure: A randomized, double‐blind, placebo‐controlled clinical trial. J Am Coll Cardiol 1999; 34:155–162 [DOI] [PubMed] [Google Scholar]
- 8. Colucci WS, Elkayam U, Horton DP, Abraham WT, Bourge RC, Jefferson AD: Intravenous nesiritide, a natriuretic peptide, in the treatment of decom‐pensated heart failure. N Engl J Med 2000; 343:246–253 [DOI] [PubMed] [Google Scholar]
- 9. Publication Committee for the VMAC Investigators : Intravenous nesiritide vs. nitroglycerin for treatment of decompensated heart failure: A randomized controlled trial. J Am Med Assoc 2002; 287:1531–1540 [DOI] [PubMed] [Google Scholar]
- 10. Weiland DS, Konstam MA, Salem DN, Martin TT, Cohen SR, Zile MR, Das D: Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. Am J Cardiol 1986; 58:1046–1050 [DOI] [PubMed] [Google Scholar]
- 11. Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M: Short‐term intravenous milrinone for acute exacerbation of chronic heart failure: A randomized controlled trial. J Am Med Assoc 2002; 287:1541–1547 [DOI] [PubMed] [Google Scholar]
- 12. Bayliss J, Norell M, Canepa‐Anson R, Sutton G, Poole‐Wilson P: Untreated heart failure: Clinical and neuroendocrine effects of introducing diuretics. Br Heart J 1987; 57:17–22 [DOI] [PMC free article] [PubMed] [Google Scholar]